Drugs for Schistosomiasis Market Size is Set to Grow at a Remarkable Pace in the Coming Years.

Portland, OR -- (SBWire) -- 08/25/2017 --Schistosomiasis is a chronic and acute disease, which is caused by parasitic trematode worms of the genus Schistosoma. This parasite is transmitted to human body when people consume infested water that contains larval forms of the parasite. Hence, this disease is mainly witnessed among people who regularly work in agricultural, domestic, occupational, and recreational sectors (that expose them to infested water). Since past few years, the prevalence of schistosomiasis is increasing continuously.

Access full summary at: https://www.alliedmarketresearch.com/drugs-for-schistosomiasis-market

This is evident from the estimates of WHO, which states that at least 218 million people required preventive treatment for schistosomiasis in 2015. Moreover, up till 2017, schistosomiasis transmission has been reported from 78 countries. Such high prevalence of the disease clearly showcases the need for effective treatment drugs that prevent schistosomiasis occurrence. Currently, praziquantel drug is the recommended treatment against all forms of schistosomiasis.

The factors that drive the growth of the global drugs for schistosomiasis market include rise in prevalence of schistosomiasis, lack of safe drinking water in developing countries, and inadequate healthcare facilities. However, high cost of drugs and stringent approval process restrains the market growth. Presence of large patient pool and unmet medical needs are anticipated to provide lucrative opportunities for the market growth.

The major players operating in the market include Shin Poong Pharma.Co., Ltd., Merck & Co., Inc., Bayer AG, Egyptian International Pharmaceuticals Industries Co SAE (EIPICO), CBC Pharma., Taj Pharmaceuticals Ltd., V.H. Bhagat Pharmaceuticals Pvt. Ltd., VHB Life Science Inc., Samarth Pharma Pvt. Ltd., and Shreeji Pharma International. The other players of the market include Avanscure Lifesciences Pvt. Ltd., 3S Corporation Kancera AB, LondonPharma Ltd, Salvensis, Meher Distributors Pvt. Ltd., and Chemos GmbH & Co. KG.

Drugs For Schistosomiasis Market Key Segments:

By Site
- Intestinal
- Urogenital

By Species Type
- Schistosoma mansoni
- Schistosoma japonicum
- Schistosoma mekongi
- Schistosoma guineensis
- Schistosoma haematobium

By Drug Type
- Praziquantel
- Metrifonate
- Biltricide
- Oxamniquine
- Others

By Region
- North America
o U.S.
o Canada
o Mexico

- Europe
o Germany
o UK
o France
o Italy
o Russia
o Rest of Europe

- Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific

- LAMEA
o Brazil
o South Africa
o South Arabia
o Egypt
o Rest of LAMEA

Request TOC and Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2702

About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com